Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CCR7 receptor antagonist

DRUG CLASS:

CCR7 receptor antagonist

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

Chronic Lymphocytic Leukemia

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials